Asian Phytoceuticals

APCO

TH1077A10Z09

Personal Products

End-of-day quote Thailand S.E. Other stock markets 23:00:00 16/05/2024 BST			5-day change	1st Jan Change
5.35 ^THB	0.00%		+9.18%	+2.88%

05-14	Asian Phytoceuticals Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-22	Asian Phytoceuticals Public Company Limited Approves Dividend for the Year 2023, Payable on May 13, 2024	CI

Asian Phytoceuticals Public Company Limited Announces Retirement of Executive Committee and Executives

January 04, 2022 at 06:08 am

Asian Phytoceuticals Public Company Limited announced the retirement of executive committee and executives as follows: Mr. Sakda Sreesangkom, Executive Committee and Chief Operating Officer (COO) and Ms. Sureeporn Teeyaprechaya, Assistant to Chief Executive Officer for Management, effective December 31, 2021.

Latest news about Asian Phytoceuticals

Asian Phytoceuticals Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	05-14	CI
Asian Phytoceuticals Public Company Limited Approves Dividend for the Year 2023, Payable on May 13, 2024	04-22	CI
Asian Phytoceuticals Public Company Limited Proposes Dividend, Payable on May 13, 2024	02-28	CI
Asian Phytoceuticals Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023	02-28	CI
Asian Phytoceuticals Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-10	CI
Asian Phytoceuticals Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	09/08/23	CI
Asian Phytoceuticals Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2023	12/05/23	CI
Asian Phytoceuticals Public Company Limited Approves Dividend, Payable on May 22, 2023	26/04/23	CI
Asian Phytoceuticals Public Company Limited Appoints Montien Sirisoonthornlak as Director	26/04/23	CI
Asian Phytoceuticals Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2022	26/02/23	CI
Asian Phytoceuticals Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	09/11/22	CI
Asian Phytoceuticals Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	11/08/22	CI
Asian Phytoceuticals Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2022	13/05/22	CI
Asian Phytoceuticals Public Company Limited Approves Dividend, Payable on May 9, 2022	18/04/22	CI
Asian Phytoceuticals Public Company Limited Announces the Establishment of Companies	28/02/22	CI
Asian Phytoceuticals Public Company Limited Proposes Dividend for 2021, Payable on May 9, 2022	28/02/22	CI
Asian Phytoceuticals Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2021	28/02/22	CI
Asian Phytoceuticals Public Company Limited Announces Retirement of Executive Committee and Executives	04/01/22	CI
Asian Phytoceuticals Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	12/11/21	CI
Asian Phytoceuticals Public Company Limited Reports Earnings Results for the Second Quarter Ended June 30, 2021	10/08/21	CI
Asian Phytoceuticals Public Company Limited Announces the Progress of Apco's Research and Development	14/05/21	CI
Asian Phytoceuticals Public Company Limited Announces Consolidated Earnings Results for the First Quarter Ended in March 31, 2021	14/05/21	CI
Asian Phytoceuticals Public Company Limited Approves Dividend, Payable on May 10, 2021	19/04/21	CI
Asian Phytoceuticals Public Company Limited Proposes Dividend, Payable on May 10, 2021	22/02/21	CI
Asian Phytoceuticals Public Company Limited Reports Audited Earnings Results for the Full Year Ended December 31, 2020	22/02/21	CI

Chart Asian Phytoceuticals

Duration

Period

More charts

Company Profile

Asian Phytoceuticals Public Company Limited is a Thailand-based company, which is engaged in business of research and development, manufacturing, and distribution of its products for health and natural beauty. It operates through the manufacturing and distribution of dietary supplements from herbs. The Companyâs products and brands include operation balancing immunity (BIM), longevity, and slimming and beauty products. Its operation BIM includes Mylife, LIV Capsule, Garcinia, Arthrinox, Diabenok, Tumorid capsule, Noriasis, Canvirol and others. The Companyâs slimming products include Asian Life Revitalizing Serum, Asian Life Revitalizing Cream, Garcinia Acne Cream, Garcinia Facial Cleansing Gel, Garcinia Cleansing Cream, Noriasis Nourishing Skin Cream, and others. The Company, through its subsidiary, Killer T Cell for Pets Co., Ltd., is engaged in the business of distribution and marketing of pharmaceutical food supplements in the global animal market.

Sector

Personal Products

Calendar

06/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Personal Products

	1st Jan change	Capi.
ASIAN PHYTOCEUTICALS	+2.88%	88.86M
UNILEVER PLC	+13.58%	143B
COLGATE-PALMOLIVE COMPANY	+18.09%	77.23B
HINDUSTAN UNILEVER LIMITED	-12.61%	65.42B
ESTEE LAUDER	-7.86%	48.32B
KENVUE INC.	-4.92%	39.2B
BEIERSDORF	+6.63%	35.21B
ESSITY AB	+11.64%	18.31B
GODREJ CONSUMER PRODUCTS LIMITED	+14.87%	15.9B
DABUR INDIA LIMITED	-3.09%	11.4B